innovative features to customers, worldwide. These include water bath and bathless dissolution, media preparation and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity and dissolution autosampling. Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications as well as the BIOne 1250, an innovative bioreactor control system for both mammalian and microbial models.
Distek’s core market includes brand name, generic and biosimilar drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies and universities. Distek holds several instrumentation and
accessory patents and has been ISO certified since 2002.